NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioInvent International AB (publ) (ST: BINV)

 
BINV Technical Analysis
5
As on 9th Jun 2023 BINV STOCK Price closed @ 19.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 42.37 & Strong Sell for SHORT-TERM with Stoploss of 39.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BINVSTOCK Price

Open 19.60 Change Price %
High 19.80 1 Day -0.36 -1.85
Low 18.90 1 Week -5.06 -20.91
Close 19.14 1 Month -8.76 -31.40
Volume 369048 1 Year -29.52 -60.67
52 Week High 50.20 | 52 Week Low 19.64
 
ST Sweden Most Active Stocks
QUIA 0.02 0.00%
QLIFE 0.04 0.00%
SBB-B 5.38 3.07%
STRLNG 0.12 33.33%
LUNE 21.97 6.65%
SAS 0.36 5.88%
URBIT 0.02 0.00%
IDOGEN 0.15 -31.82%
STAR-B 0.89 -1.11%
TELIA 24.60 0.41%
 
ST Sweden Top Gainers Stocks
S2M 0.52 100.00%
NETM-B 1.35 42.11%
STRLNG 0.12 33.33%
IVACC 7.26 32.97%
SPRINT 0.63 16.67%
TH1NG 1.61 16.67%
ATIC 5.14 15.77%
ATIC 5.14 15.77%
CIRCHE 3.69 15.67%
AXIC-A 8.16 15.25%
 
ST Sweden Top Losers Stocks
IDOGEN 0.15 -31.82%
IMMU 0.72 -27.27%
ALLR 1.55 -26.54%
MIDW-A 24.80 -22.98%
KILI 0.76 -16.48%
FRACTL 36.80 -14.02%
DIVIO-B 0.13 -13.33%
ZZ-B 41.50 -12.08%
LIPI 1.49 -11.83%
BACTI-B 72.70 -10.69%
 
 
BINV
Daily Charts
BINV
Intraday Charts
Whats New @
Bazaartrend
BINV
Free Analysis
 
BINV Important Levels Intraday
RESISTANCE20.87
RESISTANCE20.32
RESISTANCE19.97
RESISTANCE19.63
SUPPORT18.65
SUPPORT18.31
SUPPORT17.96
SUPPORT17.41
 
BINV Forecast May 2024
4th UP Forecast40.14
3rd UP Forecast33.41
2nd UP Forecast29.24
1st UP Forecast25.08
1st DOWN Forecast13.2
2nd DOWN Forecast9.04
3rd DOWN Forecast4.87
4th DOWN Forecast-1.86
 
BINV Weekly Forecast
4th UP Forecast31.47
3rd UP Forecast27.52
2nd UP Forecast25.07
1st UP Forecast22.63
1st DOWN Forecast15.65
2nd DOWN Forecast13.21
3rd DOWN Forecast10.76
4th DOWN Forecast6.81
 
BINV Forecast2024
4th UP Forecast81.19
3rd UP Forecast61.29
2nd UP Forecast48.99
1st UP Forecast36.69
1st DOWN Forecast1.59
2nd DOWN Forecast-10.71
3rd DOWN Forecast-23.01
4th DOWN Forecast-42.91
 
 
BINV Other Details
Segment EQ
Market Capital 2163430656.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BINV Address
BINV
 
BINV Latest News
 
Your Comments and Response on BioInvent International AB (publ)
 
BINV Business Profile
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, rest of Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206, a monoclonal antibody targeting CD32b, which is in Phase I/IIa clinical trials in patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia. The company is also developing cancer-associated regulatory T cells which modulate the immune system; and BI-1808 and BI-1910, an anti-TNFR2 antibody for the treatment of solid tumors and cutaneous T-cell lymphoma (CTCL). It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumour-associated myeloid cells; partnership and collaboration with Transgene to co-develop multi-functional oncolytic viruses for treatment of solid tumors; and a collaboration agreement with SkylineDx to characterize the gene expression and immunological signatures in tumors of patients pre-and post-treatment with BI-1206. The Company was incorporated in 1996 and is headquartered in Lund, Sweden. Address: The Gamma Building, Lund, Sweden, 223 70
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service